1. J. Gao, Y. Liang, and L. Wang*.Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.Front Immunol .2022.13.888713.SCI |
2. Y. Liang, H. He, W. Wang, H. Wang, S. Mo, R. Fu, X. Liu, Q. Song, Z. Xia, and L. Wang*.Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming. Mol Cancer.2022.21.182.SCI |
3. F. Peng, W. Su, A. Zhang, B. Huo, T. Song, Z. Wei, Z. Geng, and L. Wang*.Investigation of epidemiological characteristics and development of a nomogram to predict survival in primary ocular adnexal lymphoma.Clin Exp Ophthalmol.2022.50.615-631.SCI |
4. W. Guan, L. Wang*, and X. Peng*.Targeting Bruton's tyrosine kinase in vitreoretinal lymphoma: an open-label, prospective, single-center, phase 2 study.Exp Hematol Oncol.2022.11.95.SCI |
5. L. Wang, Y. Shi, J. Jiang, C. Li, H. Zhang, X. Zhang, T. Jiang, L. Wang*, Y. Wang*, and L. Feng*.Micro-Nanocarriers Based Drug Delivery Technology for Blood-Brain Barrier Crossing and Brain Tumor Targeting Therapy. Small .2022.18.e2203678.SCI |
6. Wang, Liang; Yang, Jing; Wang, He-nan; Fu, Rui-ying; Liu, Xin-di; Piao,Ying-shi; Wei, Li-qiang; Wang, Jing-wen; Zhang, Luo*. LncRNA BCYRN1-induced autophagy enhances asparaginase resistance in extranodal NK/T-cell lymphoma.Theranostics.2021.11(2).925-940.SCI |
7. Wang HN#, Yang J#, Xie DH#, Liang Z, Wang Y, Fu RY, Liu X, Xia ZJ, Jia G, Wang L*.SIngle-cell RNA sequencing infers the role of malignant cells in drug-resistant multiple myeloma.Clinical and Translational Medicine.2021.11(12).e653.SCI |
8. Wang L, Wang JW*.PD-1 blockade in extranodal NK/T-cell lymphoma: who is in charge?.Leukemia.2020.34.3432-3433.SCI |
9. Liang Wang*, Jing-wen Wang.Extranodal natural-killer T-cell lymphoma:experience from China.The Lancet Haematology.2020.7(6).e441.SCI |
10. Wang, Liang*; Li, Lin-Rong; Zhang, Luo; Wang, Jing-Wen.The landscape of new drugs in extranodal NK/T-cell lymphoma.Cancer Treatment Reviews.2020.89.102065.SCI |
11. Wang, Liang*; Li, Lin-rong; Young, Ken H*.New agents and regimens for diffuse large B cell lymphoma. J Hematol Oncol.2020.13.175.SCI |
12. Qiu-yu Lai#, Ying-zhi He#, Xiong-wen Peng#, Xuan Zhou, Dan Liang, Liang Wang*.Histone deacetylase 1 induced by neddylation inhibition contributes to drug resistance in acute myelogenous leukemia.Cell Communication and Signaling.2019.17.86.SCI |
13. Liang Wang#* , Xi‑wen Bi#, Yu‑jia Zhu, Ying‑zhi He, Qiu‑yu Lai, Zhong‑jun Xia, Qing‑qing Cai*.IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma..Cancer communications.2018.38.62.SCI |
14. Xi-wen Bi#, Hua Wang#, Wen-wen Zhang#, Jing-hua Wang, Wen-jian Liu, Zhong-jun Xia,Hui-qiang Huang, Wen-qi Jiang, Yu-jing Zhang, Liang Wang*.PD-L1 is upregulated by EBV-driven LMP1 through NF-kappaB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma..Journal of hematology & oncology.2016.9.109.SCI |
15. Liang Wang#, Zhong-jun Xia, Yue Lu,Yu-jing Zhang*.Prophylactic cervical lymph node irradiation provides no benefit for patients of stage IE extranodal natural killer/T cell lymphoma, nasal type.Medical oncology.2015.32.320.SCI |
16. Liang Wang#*, Hua Wang#, Peng-fei Li,Yue Lu, Zhong-jun Xia, Hui-qiang Huangm, Yu-jing Zhang.CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal nk/t cell lymphoma, nasal type..Annals of hematology.2015.94.1381-1388.SCI |